BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agarwal D, Udoji MA, Trescot A. Genetic Testing for Opioid Pain Management: A Primer. Pain Ther 2017;6:93-105. [PMID: 28409480 DOI: 10.1007/s40122-017-0069-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, Nolin TD, Becker WC, Fischer MJ; HOPE Consortium. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nat Rev Nephrol 2021. [PMID: 34621058 DOI: 10.1038/s41581-021-00484-6] [Reference Citation Analysis]
2 Mitra S, Carlyle D, Kodumudi G, Kodumudi V, Vadivelu N. New Advances in Acute Postoperative Pain Management. Curr Pain Headache Rep 2018;22:35. [PMID: 29619627 DOI: 10.1007/s11916-018-0690-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 8.8] [Reference Citation Analysis]
3 Broyles AD, Banerji A, Castells M. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts. J Allergy Clin Immunol Pract 2020;8:S3-S15. [PMID: 32791249 DOI: 10.1016/j.jaip.2020.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
4 Peiró AM. Pharmacogenetics in Pain Treatment. Pharmacogenetics. Elsevier; 2018. pp. 247-73. [DOI: 10.1016/bs.apha.2018.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Horvat CM, Martin B, Wu L, Fabio A, Empey PE, Hagos F, Bigelow S, Kantawala S, Au AK, Kochanek PM, Clark RSB. Opioid e-prescribing trends at discharge in a large pediatric health system. J Opioid Manag 2019;15:119-27. [PMID: 31343713 DOI: 10.5055/jom.2019.0493] [Reference Citation Analysis]
6 Cornett EM, Carroll Turpin MA, Pinner A, Thakur P, Sekaran TSG, Siddaiah H, Rivas J, Yates A, Huang GJ, Senthil A, Khurmi N, Miller JL, Stark CW, Urman RD, Kaye AD. Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. Curr Oncol Rep 2020;22:18. [PMID: 32030524 DOI: 10.1007/s11912-020-0865-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Slepukhina MA, Ivashchenko DV, Sheina MA, Muradian AA, Blagovestnov DA, Sychev DA. Pain pharmacogenetics. Drug Metab Pers Ther 2020;35. [PMID: 32776897 DOI: 10.1515/dmpt-2020-2939] [Reference Citation Analysis]
8 V Subramaniam A, Salem Yehya AH, Oon CE. Molecular Basis of Cancer Pain Management: An Updated Review. Medicina (Kaunas) 2019;55:E584. [PMID: 31547335 DOI: 10.3390/medicina55090584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kapur BM, Aleksa K. What the lab can and cannot do: clinical interpretation of drug testing results. Crit Rev Clin Lab Sci 2020;57:548-85. [PMID: 32609540 DOI: 10.1080/10408363.2020.1774493] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sekhri NK, Cooney MF. Opioid Metabolism and Pharmacogenetics: Clinical Implications. J Perianesth Nurs 2017;32:497-505. [PMID: 28938988 DOI: 10.1016/j.jopan.2017.07.005] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
11 Friedman A, Nabong L. Opioids: Pharmacology, Physiology, and Clinical Implications in Pain Medicine. Phys Med Rehabil Clin N Am 2020;31:289-303. [PMID: 32279731 DOI: 10.1016/j.pmr.2020.01.007] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Moulder JK, Boone JD, Buehler JM, Louie M. Opioid Use in the Postoperative Arena: Global Reduction in Opioids After Surgery Through Enhanced Recovery and Gynecologic Surgery. Clin Obstet Gynecol 2019;62:67-86. [PMID: 30407228 DOI: 10.1097/GRF.0000000000000410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Katz N. Design and conduct of confirmatory chronic pain clinical trials. Pain Rep 2021;6:e845. [PMID: 33511323 DOI: 10.1097/PR9.0000000000000854] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Cacabelos R, Cacabelos N, Carril JC. The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 2019;12:407-42. [DOI: 10.1080/17512433.2019.1597706] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
15 Bugada D, Lorini LF, Fumagalli R, Allegri M. Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain. Cancers (Basel) 2020;12:E1951. [PMID: 32708424 DOI: 10.3390/cancers12071951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Häuser W, Morlion B, Vowles KE, Bannister K, Buchser E, Casale R, Chenot JF, Chumbley G, Drewes AM, Dom G, Jutila L, O'Brien T, Pogatzki-Zahn E, Rakusa M, Suarez-Serrano C, Tölle T, Krčevski Škvarč N. European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: Role of opioids in the management of chronic noncancer pain. Eur J Pain 2021;25:949-68. [PMID: 33655607 DOI: 10.1002/ejp.1736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
17 Nadeau SE, Wu JK, Lawhern RA. Opioids and Chronic Pain: An Analytic Review of the Clinical Evidence. Front Pain Res 2021;2:721357. [DOI: 10.3389/fpain.2021.721357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schutijser BCFM, Jongerden I, Klopotowska JE, Moesker M, Langelaan M, Wagner C, de Bruijne M. Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies. BMJ Open 2020;10:e038037. [PMID: 32998923 DOI: 10.1136/bmjopen-2020-038037] [Reference Citation Analysis]
19 Haga SB. Integrating pharmacogenetic testing into primary care. Expert Rev Precis Med Drug Dev 2017;2:327-36. [PMID: 31853504 DOI: 10.1080/23808993.2017.1398046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
20 Muradian AA, Sychev DA, Blagovestnov DA, Sozaeva ZA, Akmalova KA, Zastrozhin MS, Kerimova LN, Koroshvili VT, Epifanova IA. The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug Metab Pers Ther 2021. [PMID: 34246203 DOI: 10.1515/dmdi-2021-0112] [Reference Citation Analysis]
21 Marti KE, Marti KM, Salvo MC. Pharmacist's role in pharmacogenomics and pain management. J Am Pharm Assoc (2003) 2020;60:290. [PMID: 31813751 DOI: 10.1016/j.japh.2019.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Fredrikson KM, Fasolino T. Pharmacogenetic testing: Clinical integration and application for chronic pain management. Nurse Pract 2021;46:12-9. [PMID: 33739321 DOI: 10.1097/01.NPR.0000737180.73290.1f] [Reference Citation Analysis]
23 Chadwick A, Frazier A, Khan TW, Young E. Understanding the Psychological, Physiological, and Genetic Factors Affecting Precision Pain Medicine: A Narrative Review. J Pain Res 2021;14:3145-61. [PMID: 34675643 DOI: 10.2147/JPR.S320863] [Reference Citation Analysis]
24 Panella L, Volontè L, Poloni N, Caserta A, Ielmini M, Caselli I, Lucca G, Callegari C. Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study. Medicina (Kaunas) 2019;55:E147. [PMID: 31100953 DOI: 10.3390/medicina55050147] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Medina R, Sorrell T, Techau A, Weiss J. Treating chronic pain and opioid misuse disorder among underserved populations in Colorado. J Am Assoc Nurse Pract 2019;31:766-72. [PMID: 31169790 DOI: 10.1097/JXX.0000000000000238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Jones JD, Mumtaz M, Manubay JM, Mogali S, Sherwin E, Martinez S, Comer SD. Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone. Pharmacol Biochem Behav 2019;186:172778. [PMID: 31493434 DOI: 10.1016/j.pbb.2019.172778] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Faria J, Barbosa J, Moreira R, Queirós O, Carvalho F, Dinis-Oliveira RJ. Comparative pharmacology and toxicology of tramadol and tapentadol. Eur J Pain 2018;22:827-44. [PMID: 29369473 DOI: 10.1002/ejp.1196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
28 Morlock R, Braunstein GD. Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic pain. Pain Rep 2017;2:e615. [PMID: 29392230 DOI: 10.1097/PR9.0000000000000615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Benjeddou M, Peiró AM. Pharmacogenomics and prescription opioid use. Pharmacogenomics 2021;22:235-45. [PMID: 33445954 DOI: 10.2217/pgs-2020-0032] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Parikh JM, Amolenda P, Rutledge J, Szabova A, Chidambaran V. An update on the safety of prescribing opioids in pediatrics. Expert Opin Drug Saf 2019;18:127-43. [PMID: 30650988 DOI: 10.1080/14740338.2019.1571037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
31 Muradian AA, Sychev DA, Blagovestnov DA, Sozaeva ZA, Akmalova KA, Zastrozhin MS, Kerimova LN, Koroshvili VT, Epifanova IA. The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy. Drug Metab Pers Ther 2021;37:27-34. [PMID: 35385894 DOI: 10.1515/dmpt-2021-0112] [Reference Citation Analysis]
32 Alizadeh R, Aghsaie Fard Z. Renal impairment and analgesia: From effectiveness to adverse effects. J Cell Physiol 2019;234:17205-11. [PMID: 30916404 DOI: 10.1002/jcp.28506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]